tradingkey.logo

Evogene Ltd

EVGN
View Detailed Chart

1.520USD

-0.290-16.02%
Close 06/12, 16:00ETQuotes delayed by 15 min
10.14MMarket Cap
LossP/E TTM

Evogene Ltd

1.520

-0.290-16.02%
Intraday
1m
30m
1h
D
W
M
D

Today

-16.02%

5 Days

+37.56%

1 Month

+34.51%

6 Months

+14.29%

Year to Date

-18.72%

1 Year

+130.23%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 2 analysts
BUY
Current Rating
3.500
Target Price
93.37%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

557
Total
5
Median
6
Average
Company name
Ratings
Analysts
Evogene Ltd
EVGN
2
Intellia Therapeutics Inc
NTLA
28
Exact Sciences Corp
EXAS
28
CRISPR Therapeutics AG
CRSP
28
Regeneron Pharmaceuticals Inc
REGN
28
Moderna Inc
MRNA
26
1
2
3
...
112

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

1m
15m
30m
1h
D
W
M
1m
15m
30m
D
Buy
Sell(3)
Neutral(2)
Buy(8)
Indicators
Sell(2)
Neutral(2)
Buy(3)
Indicators
Value
Direction
MACD(12,26,9)
0.168
Buy
RSI(14)
66.047
Neutral
STOCH(KDJ)(9,3,3)
62.934
Neutral
ATR(14)
0.173
High Vlolatility
CCI(14)
192.694
Buy
Williams %R
44.853
Buy
TRIX(12,20)
0.510
Sell
StochRSI(14)
51.963
Sell
Moving Average
Sell(1)
Neutral(0)
Buy(5)
Indicators
Value
Direction
MA5
1.481
Buy
MA10
1.292
Buy
MA20
1.252
Buy
MA50
1.176
Buy
MA100
1.323
Buy
MA200
1.767
Sell

News

More news coming soon, stay tuned...

Company

Evogene Ltd is an Israel-based company, engaged in leveraging computational biology to design products for life-science-based industries including human health, agriculture, and industrial applications. Leveraging Big Data and Artificial Intelligence while incorporating a deep understanding of biology, Evogene established its technology, the Computational Predictive Biology (CPB) platform, to computationally design microbes, small molecules and genes as the core components for life-science products. Evogene holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production.
Ticker SymbolEVGN
CompanyEvogene Ltd
CEODr. Arnon Heyman
Websitehttps://evogene.com/
KeyAI